Related Experiment Video
Updated: Jul 15, 2026

11:49
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Th1-Adapted Regulatory T Cells in Tumor Immunity and Inflammatory Diseases
Ayumi Kuratani1,2, Masaaki Okamoto3, Takashi Kobayashi3,4
1Department of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka 565-0871, Japan.
International Immunology
|July 14, 2026
Summary
Regulatory T cells (Tregs) are not static; they specialize into Th1-Tregs to control type 1 immunity. These adaptable cells play dual roles in cancer and autoimmune diseases.
Area of Science:
- Immunology
- Cellular and Molecular Immunology
- Immune Regulation
Background:
- Regulatory T cells (Tregs) are crucial for immune tolerance and inflammation control.
- Evidence shows Tregs are heterogeneous and adapt to local inflammatory environments.
- Th1-type Tregs (Th1-Tregs), expressing Foxp3 and T-bet, are key regulators of type 1 immune responses.
Purpose of the Study:
- To review the molecular mechanisms of Th1-Treg differentiation.
- To discuss the context-dependent roles of Th1-Tregs in various diseases.
- To highlight the adaptability of Tregs in modulating immune responses.
Main Methods:
- Review of recent scientific literature on Th1-Tregs.
- Analysis of molecular pathways governing Th1-Treg specialization.
- Examination of Th1-Treg function in different pathological contexts (cancer, autoimmunity, infection).
Main Results:
- Th1-Tregs express CXCR3, localizing them to IFN-γ-rich sites.
- In tumors, Th1-Tregs suppress anti-tumor immunity, promoting immune evasion.
- In autoimmune diseases and infections, Th1-Tregs limit excessive inflammation, protecting tissues.
Conclusions:
- Regulatory T cells dynamically adapt to inflammatory environments, specializing into subsets like Th1-Tregs.
- Th1-Tregs exhibit context-dependent functions, suppressing immunity in cancer but protecting hosts in autoimmunity and infection.
- Understanding Th1-Treg specialization is key to developing targeted immunotherapies.
Related Concept Videos
T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cell-mediated Immune Responses
Overview
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...